What it sells
Automates life sciences paperwork
Business model breakdown
Buyer: who owns the budget?
UnverifiedR&D, quality and regulatory leaders at life-sciences companies
Trigger: what makes them buy now?
Laborious document generation and review across preclinical/clinical trials and quality management slows time to market.
Workflow: what inputs become what output?
AI platform drafts and reviews regulated documents and checks changes against quality standards across R&D, trials, QMS and product delivery.
Distribution: how it reaches customers
Demo-led ("Book a demo", contact form).
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-06-03 | Series B | $95M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.